Truist Securities Maintains Buy Rating, PT Down to $17 from $19

Truist Securities Maintains Buy Rating, PT Down to $17 from $19

Truist Securities has maintained a "Buy" rating for Truist Financial Corporation (NYSE: TFC), but has revised its price target downwards from $19 to $17. This adjustment comes amidst mixed earnings reports and varying analyst sentiments.

Truist Financial recently reported earnings of $0.91 per share, missing analysts' expectations by $0.02. Revenue matched projections at $5.04 billion. Despite the mixed results, Raymond James upgraded the company's rating to "outperform" with a new price target of $50.00, reflecting positive market sentiment [3].

The company's stock has seen significant insider activity. Bradley D. Bender sold 12,540 shares of the stock on July 22nd, representing a 96.17% decrease in their ownership. This sale was disclosed in a legal filing with the Securities & Exchange Commission [3].

Institutional investors have also shown interest in Truist Financial. National Bank of Canada FI increased its holdings by 178.0% in the first quarter, owning 2,289,868 shares worth $94,228,000 at the end of the most recent reporting period. Several other institutional investors, including Capital International Investors and Victory Capital Management Inc., have also increased their holdings in the last quarter [3].

Truist Financial's stock has been volatile, trading up 0.5% on July 2nd, hitting $43.08. The stock has a market cap of $55.55 billion, a P/E ratio of 11.74, and a dividend yield of 4.8% [3].

Despite the mixed earnings and insider selling, Truist Securities maintains a positive outlook on the company, reflecting the broader market sentiment. Investors should continue to monitor Truist Financial's earnings calls and future analyst revisions for more insights into the company's performance and potential stock price movements.

References:
[1] https://www.marketbeat.com/instant-alerts/filing-truist-financial-corporation-nysetfc-stake-boosted-by-national-bank-of-canada-fi-2025-08-09/
[2] https://www.nasdaq.com/articles/m-com-mtsi-reports-q3-earnings-what-key-metrics-have-say
[3] https://www.theglobeandmail.com/investing/markets/stocks/IRTC/pressreleases/33839086/wells-fargo-remains-a-buy-on-irhythm-technologies-irtc/